Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lo

Showing results (871-880 of 1,300) with videos related to

Pageof 130
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2R Debets, J C Timans, B Homey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selectionShelly S Lo, Patricia B Mumby, John Norton, et al.
Stereotactic and Functional Neurosurgery|September 2, 2008
Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenomaBrent A Tinnel, Mark A Henderson, Thomas C Witt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesisLea M Starita, Jonathan N Pruneda, Russell S Lo, et al.
Future Oncology (London, England)|November 5, 2016
Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic reviewAtallah Baydoun, Bryan Traughber, Nathan Morris, et al.
Journal of Neuro-Oncology|March 25, 2006
The role of Gamma Knife Radiosurgery in the management of unresectable gross disease or gross residual disease after surgery in ependymomaSimon S Lo, Ramzi Abdulrahman, Paul M Desrosiers, et al.
HIV Medicine|May 31, 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparisonL Taramasso, A Di Biagio, F Maggiolo, et al.
Neuro-Oncology|April 13, 2019
Updates in the management of intradural spinal cord tumors: a radiation oncology focusRupesh Kotecha, Minesh P Mehta, Eric L Chang, et al.
Frontiers in Oncology|December 18, 2020
Clinical Study of Using Biometrics to Identify Patient and ProcedureJason W Sohn, Haksoo Kim, Samuel B Park, et al.
JAMA Oncology|June 13, 2024
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive TumorsElysia K Donovan, Simon S Lo, Sushil Beriwal, et al.
Pageof 130

Showing results (871-880 of 1,300) with videos related to

Sort By:
Pageof 130
Journal of Immunology (Baltimore, Md. : 1950)|July 24, 2001
Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2R Debets, J C Timans, B Homey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selectionShelly S Lo, Patricia B Mumby, John Norton, et al.
Stereotactic and Functional Neurosurgery|September 2, 2008
Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenomaBrent A Tinnel, Mark A Henderson, Thomas C Witt, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesisLea M Starita, Jonathan N Pruneda, Russell S Lo, et al.
Future Oncology (London, England)|November 5, 2016
Outcomes and toxicities in patients treated with definitive focal therapy for primary prostate cancer: systematic reviewAtallah Baydoun, Bryan Traughber, Nathan Morris, et al.
Journal of Neuro-Oncology|March 25, 2006
The role of Gamma Knife Radiosurgery in the management of unresectable gross disease or gross residual disease after surgery in ependymomaSimon S Lo, Ramzi Abdulrahman, Paul M Desrosiers, et al.
HIV Medicine|May 31, 2018
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparisonL Taramasso, A Di Biagio, F Maggiolo, et al.
Neuro-Oncology|April 13, 2019
Updates in the management of intradural spinal cord tumors: a radiation oncology focusRupesh Kotecha, Minesh P Mehta, Eric L Chang, et al.
Frontiers in Oncology|December 18, 2020
Clinical Study of Using Biometrics to Identify Patient and ProcedureJason W Sohn, Haksoo Kim, Samuel B Park, et al.
JAMA Oncology|June 13, 2024
Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive TumorsElysia K Donovan, Simon S Lo, Sushil Beriwal, et al.
Pageof 130